Home » Topics » BioWorld Science

BioWorld Science
RSS

Catabasis and Gates MRI to study CAT-5571 in drug-sensitive and drug-resistant tuberculosis

Aug. 5, 2020

Independent IRB grants approval for phase II study of LSALT peptide in severe COVID-19

Aug. 5, 2020

In vitro data show VERU-111 suppresses key cytokines responsible for severe ARDS in COVID-19

Aug. 5, 2020

Regenxbio reports positive interim phase I/IIa data and program updates for RGX-314

Aug. 5, 2020

BiSiChem identifies new ALK inhibitors

Aug. 5, 2020

Dogma Therapeutics describes PCSK9 inhibitors

Aug. 5, 2020

Biogen synthesizes new IRAK-4 inhibitors

Aug. 5, 2020

Minghui Pharmaceutical presents new BTK inhibitors

Aug. 5, 2020

Chinese investigators patent IDO1 inhibitors

Aug. 5, 2020

Novel humanized platelet mouse model predicts efficacy of experimental antiplatelet drugs

Aug. 5, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...